Sfoglia per Autore
Enhancement of Glycine release from human brain cortex by acetylcholine acting at M4 muscarinic receptors
1993-01-01 Russo, Claudio; Marchi, M.; Andrioli, G. C.; Cavazzani, P.; Raiteri, M.
Presence of soluble amyloid b peptide precedes amyloid plaque formation in Down’s syndrome
1996-01-01 Teller, J. K.; Russo, Claudio; Debusk, L. M.; Angelini, G.; Zaccheo, D.; DAGNA BRICARELLI, F.; Scartezzini, P.; Bertolini, S.; Mann, D. M. A.; Tabaton, M.; Gambetti, P.
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome
1997-01-01 Russo, Claudio; Saido, T. C.; Debusk, L. M.; Tabaton, M.; Gambetti, P.; Teller, J. K.
Human brain amyloidoses
1998-01-01 Gambetti, P.; Russo, Claudio
Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease
1998-01-01 Russo, Claudio; Angelini, G.; Dapino, D.; Piccini, A.; Piombo, G.; Schettini, G.; Chen, S.; Teller, J. K.; Zaccheo, D.; Gambetti, P.; Tabaton, M.
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid β-protein precursor
2000-01-01 Passer, B.; Pellegrini, L.; Russo, Claudio; Siegel, R. M.; Lenardo, M. J.; Schettini, G.; Bachmann, M.; Tabaton, M.; D'Adamio, L.
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain
2000-01-01 Capellari, S.; Parchi, P.; Russo, Claudio; Sanford, J.; Sy, M. S.; Gambetti, P.; Petersen, R. B.
Presenilin-1 mutations in Alzheimer's disease
2000-01-01 Russo, Claudio; Schettini, G.; Saido, T. C.; Hulette, C.; Lippa, C.; Lannfelt, L.; Ghetti, B.; Gambetti, P.; Tabaton, M.; Teller, J. K.
Identification of amino-terminally and phosphotyrosine modified carboxy-terminal fragments of the amyloid precursor protein in Alzheimer’s disease and Down’s syndrome brain
2001-01-01 Russo, Claudio; Salis, S.; Dolcini, V.; Venezia, V.; Xiang, S.; Teller, J. K.; Schettini, G.
The β-amyloid precursor protein APP is tyrosine phosphorilated in cells expressing a constitutively active form of the Abl protoncogene
2001-01-01 Zambrano, N.; Bruni, P.; Minopoli, G.; Mosca, R.; Molino, D.; Russo, Claudio; Schettini, G.; Sudol, M.; Russo, T.
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases
2001-01-01 Gambetti, P.; Parchi, P.; Capellari, S.; Russo, Claudio; Tabaton, M.; Teller, J. K.; Chen, S. G.
Alzheimer's disease: Molecular consequences of presenilin-1 mutation
2001-01-01 Russo, Claudio; Schettini, G.; Saido, T. C.; Hulette, C.; Lippa, C.; Lannfelt, L.; Ghetti, B.; Gambetti, P.; Tabaton, M.; Teller, J. K.
N-Terminally truncated amyloid b peptides and Alzheimer's disease
2001-01-01 Russo, Claudio; Schettini, G.; Saido, T. C.; Gambetti, P.; Tabaton, M.; Teller, J. K.
Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-kB activation
2002-01-01 Bisaglia, M.; Venezia, V.; Piccioli, P.; Stanzione, S.; Porcile, C.; Russo, Claudio; Mancini, F.; Milanese, C.; Schettini, G.
Pyroglutamate-modified amyloid β-peptides - aβN3(pE) - strongly affect cultured neuron and astrocyte survival
2002-01-01 Russo, Claudio; Violani, E; Salis, S; Venezia, V; Dolcini, V; Damonte, G; Benatti, U; D'Arrigo, C; Patrone, E; Carlo, P; Schettini, G.
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain
2002-01-01 Russo, Claudio; Dolcini, V.; Salis, S.; Venezia, V.; Zambrano, N.; Russo, T.; Schettini, G.
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain
2002-01-01 Russo, Claudio; Dolcini, V.; Salis, S.; Venezia, V.; Violani, E.; Carlo, P.; Zambrano, N.; Russo, T.; Schettini, G.
Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein
2002-01-01 Corsaro, A.; Thellung, S.; Russo, Claudio; Villa, V.; Arena, S.; D'Adamo, M. C.; Paludi, D.; ROSSI PRINCIPE, D.; Damonte, G.; Benatti, U.; Aceto, A.; Tagliavini, F.; Schettini, G.; Florio, T.
Molecular aspects of neurodegeneration in Alzheimer’s disease
2002-01-01 Russo, Claudio; Venezia, V.; Salis, S.; Dolcini, V.; Schettini, G.
Presenilin1 modulation of amyloid precursor protein processing: occurrence and relevance of N-truncated β-amyloid and carboxy-terminal fragments in AD pathology
2003-01-01 Russo, Claudio; Dolcini, V; Salis, S; Venezia, V; Violani, E; Carlo, P. AND SCHETTINI G.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Enhancement of Glycine release from human brain cortex by acetylcholine acting at M4 muscarinic receptors | 1-gen-1993 | Russo, Claudio; Marchi, M.; Andrioli, G. C.; Cavazzani, P.; Raiteri, M. | |
Presence of soluble amyloid b peptide precedes amyloid plaque formation in Down’s syndrome | 1-gen-1996 | Teller, J. K.; Russo, Claudio; Debusk, L. M.; Angelini, G.; Zaccheo, D.; DAGNA BRICARELLI, F.; Scartezzini, P.; Bertolini, S.; Mann, D. M. A.; Tabaton, M.; Gambetti, P. | |
Heterogeneity of water-soluble amyloid b-peptide in Alzheimer’s disease and Down’s syndrome | 1-gen-1997 | Russo, Claudio; Saido, T. C.; Debusk, L. M.; Tabaton, M.; Gambetti, P.; Teller, J. K. | |
Human brain amyloidoses | 1-gen-1998 | Gambetti, P.; Russo, Claudio | |
Opposite roles of apolipoprotein E in normal brains and in Alzheimer’s disease | 1-gen-1998 | Russo, Claudio; Angelini, G.; Dapino, D.; Piccini, A.; Piombo, G.; Schettini, G.; Chen, S.; Teller, J. K.; Zaccheo, D.; Gambetti, P.; Tabaton, M. | |
Generation of an apoptotic intracellular peptide by gamma-secretase cleavage of Alzheimer's amyloid β-protein precursor | 1-gen-2000 | Passer, B.; Pellegrini, L.; Russo, Claudio; Siegel, R. M.; Lenardo, M. J.; Schettini, G.; Bachmann, M.; Tabaton, M.; D'Adamio, L. | |
Effect of the E200K mutation on prion protein metabolism. Comparative study of a cell model and human brain | 1-gen-2000 | Capellari, S.; Parchi, P.; Russo, Claudio; Sanford, J.; Sy, M. S.; Gambetti, P.; Petersen, R. B. | |
Presenilin-1 mutations in Alzheimer's disease | 1-gen-2000 | Russo, Claudio; Schettini, G.; Saido, T. C.; Hulette, C.; Lippa, C.; Lannfelt, L.; Ghetti, B.; Gambetti, P.; Tabaton, M.; Teller, J. K. | |
Identification of amino-terminally and phosphotyrosine modified carboxy-terminal fragments of the amyloid precursor protein in Alzheimer’s disease and Down’s syndrome brain | 1-gen-2001 | Russo, Claudio; Salis, S.; Dolcini, V.; Venezia, V.; Xiang, S.; Teller, J. K.; Schettini, G. | |
The β-amyloid precursor protein APP is tyrosine phosphorilated in cells expressing a constitutively active form of the Abl protoncogene | 1-gen-2001 | Zambrano, N.; Bruni, P.; Minopoli, G.; Mosca, R.; Molino, D.; Russo, Claudio; Schettini, G.; Sudol, M.; Russo, T. | |
Mechanisms of phenotypic heterogeneity in prion, Alzheimer and other conformational diseases | 1-gen-2001 | Gambetti, P.; Parchi, P.; Capellari, S.; Russo, Claudio; Tabaton, M.; Teller, J. K.; Chen, S. G. | |
Alzheimer's disease: Molecular consequences of presenilin-1 mutation | 1-gen-2001 | Russo, Claudio; Schettini, G.; Saido, T. C.; Hulette, C.; Lippa, C.; Lannfelt, L.; Ghetti, B.; Gambetti, P.; Tabaton, M.; Teller, J. K. | |
N-Terminally truncated amyloid b peptides and Alzheimer's disease | 1-gen-2001 | Russo, Claudio; Schettini, G.; Saido, T. C.; Gambetti, P.; Tabaton, M.; Teller, J. K. | |
Acetaminophen protects hippocampal neurons and PC12 cultures from amyloid β-peptides induced oxidative stress and reduces NF-kB activation | 1-gen-2002 | Bisaglia, M.; Venezia, V.; Piccioli, P.; Stanzione, S.; Porcile, C.; Russo, Claudio; Mancini, F.; Milanese, C.; Schettini, G. | |
Pyroglutamate-modified amyloid β-peptides - aβN3(pE) - strongly affect cultured neuron and astrocyte survival | 1-gen-2002 | Russo, Claudio; Violani, E; Salis, S; Venezia, V; Dolcini, V; Damonte, G; Benatti, U; D'Arrigo, C; Patrone, E; Carlo, P; Schettini, G. | |
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain | 1-gen-2002 | Russo, Claudio; Dolcini, V.; Salis, S.; Venezia, V.; Zambrano, N.; Russo, T.; Schettini, G. | |
Signal transduction through tyrosine-phosphorylated carboxy-terminal fragments of APP via an enhanced interaction with Shc/Grb2 adaptor proteins in reactive astrocytes of Alzheimer's disease brain | 1-gen-2002 | Russo, Claudio; Dolcini, V.; Salis, S.; Venezia, V.; Violani, E.; Carlo, P.; Zambrano, N.; Russo, T.; Schettini, G. | |
Expression in E. coli and purification of recombinant fragments of wild type and mutant human prion protein | 1-gen-2002 | Corsaro, A.; Thellung, S.; Russo, Claudio; Villa, V.; Arena, S.; D'Adamo, M. C.; Paludi, D.; ROSSI PRINCIPE, D.; Damonte, G.; Benatti, U.; Aceto, A.; Tagliavini, F.; Schettini, G.; Florio, T. | |
Molecular aspects of neurodegeneration in Alzheimer’s disease | 1-gen-2002 | Russo, Claudio; Venezia, V.; Salis, S.; Dolcini, V.; Schettini, G. | |
Presenilin1 modulation of amyloid precursor protein processing: occurrence and relevance of N-truncated β-amyloid and carboxy-terminal fragments in AD pathology | 1-gen-2003 | Russo, Claudio; Dolcini, V; Salis, S; Venezia, V; Violani, E; Carlo, P. AND SCHETTINI G. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile